Increases amount of cigarette and other tobacco product tax revenues provided to New Jersey Commission on Cancer Research from $1 million to $4 million; establishes dedicated, non-lapsing Cancer Research Fund.

S 817 increases tobacco tax revenues allocated to New Jersey's Commission on Cancer Research from $1 million to $4 million annually. It creates a dedicated, non-lapsing "Cancer Research Fund" within the State Treasury, ensuring these funds cannot be diverted to other state purposes. The fund will hold tobacco tax revenues plus interest, which must be used exclusively for approved cancer research grants and the Commission's authorized activities. This change replaces the previous system where funds were deposited into a lapsing account subject to annual budget reallocation.